KELSEY KEY: Open Payments
NPI 1225734999 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 27 payments from 6 companies in 2025. Trend: 2023 $450 · 2024 $590 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $197 |
| Amgen Inc. | 4 | $82 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, KRYSTEXXA, CAPLYTA, Wegovy, NUZYRA, OTEZLA.
Industry payments across GA — which companies pay providers there.
